GRTX · Categories · Form 4

GRTX - SEC Form 4 insider transactions

Galera Therapeutics Inc. (GRTX) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for GRTX

• 28d
  SEC Form 4 filed by Friedman Michael R.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 28d
  SEC Form 4 filed by Chang Nancy T

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 164d
  President and CEO Sorensen Mel sold $1,407 worth of shares (70,000 units at $0.02), decreasing direct ownership by 26% to 195,029 units (SEC Form 4)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 367d
  SEC Form 4 filed by Chief Accounting Officer Sussman Joel F.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 367d
  SEC Form 4 filed by President and CEO Sorensen Mel

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 435d
  SEC Form 4 filed by Director Lokay Kevin G

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 435d
  SEC Form 4 filed by Director Friedman Michael R.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 435d
  SEC Form 4 filed by Director Chang Nancy T

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 435d
  SEC Form 4 filed by Director Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 490d
  SEC Form 4 filed by Director Friedman Michael R.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 625d
  President and CEO Sorensen Mel sold $4,825 worth of shares (67,015 units at $0.07), decreasing direct ownership by 20% to 265,029 units (SEC Form 4)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1037d
  SEC Form 4 filed by Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1037d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1056d
  SEC Form 4 filed by Powell Michael

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1056d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1056d
  SEC Form 4 filed by Cunningham Emmett

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1056d
  SEC Form 4 filed by Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1056d
  SEC Form 4 filed by Lokay Kevin G

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1144d
  SEC Form 4 filed by Galera Therapeutics Inc.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1150d
  SEC Form 4: Degnan Chris bought $19,593 worth of shares (10,000 units at $1.96)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1150d
  SEC Form 4: Sorensen Mel bought $168,120 worth of shares (100,000 units at $1.68), increasing direct ownership by 43% to 332,044 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1164d
  SEC Form 4 filed by Stacey Jennifer Evans

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1164d
  SEC Form 4 filed by Kennedy Eugene P.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1164d
  SEC Form 4 filed by Bachleda Mark

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1164d
  SEC Form 4 filed by Sorensen Mel

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1164d
  SEC Form 4 filed by Beardsley Robert A

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1164d
  SEC Form 4 filed by Degnan Chris

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1262d
  SEC Form 4: Beardsley Robert A exercised 10,000 shares at a strike of $1.07, increasing direct ownership by 10% to 108,191 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1332d
  SEC Form 4: Beardsley Robert A exercised 10,000 shares at a strike of $1.07, increasing direct ownership by 11% to 98,191 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1343d
  SEC Form 4 filed by Kennedy Eugene P.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1387d
  SEC Form 4: Alleva Lawrence M gifted 4,000 shares, decreasing direct ownership by 63% to 2,325 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1402d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1421d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1421d
  SEC Form 4 filed by Lokay Kevin G

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1421d
  SEC Form 4 filed by Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1421d
  SEC Form 4 filed by Powell Michael

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1421d
  SEC Form 4 filed by Cunningham Emmett

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1527d
  SEC Form 4 filed by Beardsley Robert A

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1527d
  SEC Form 4 filed by Degnan Chris

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1527d
  SEC Form 4 filed by Holmlund Jon T

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1527d
  SEC Form 4 filed by Stacey Jennifer Evans

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1527d
  SEC Form 4 filed by Bachleda Mark

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1527d
  SEC Form 4 filed by Sorensen Mel

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1599d
  SEC Form 4: West Linda bought $54,804 worth of shares (20,000 units at $2.74), increasing direct ownership by 50% to 60,000 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1599d
  SEC Form 4: Beardsley Robert A exercised 20,000 shares at a strike of $1.07, increasing direct ownership by 29% to 88,191 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1668d
  SEC Form 4 filed by Bachleda Mark

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1668d
  SEC Form 4 filed by Stacey Jennifer Evans

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1707d
  SEC Form 4: Holmlund Jon T sold $404,498 worth of Common Stock (47,756 units at $8.47) and exercised 47,756 units of Common Stock at a strike of $2.43

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1766d
  SEC Form 4 filed by Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1766d
  SEC Form 4 filed by Cunningham Emmett

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1766d
  SEC Form 4 filed by West Linda

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1785d
  SEC Form 4 filed by LOKAY KEVIN G

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1785d
  SEC Form 4 filed by Alleva Lawrence M

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1785d
  SEC Form 4: West Linda bought $91,300 worth of Common Stock (10,000 units at $9.13), increasing direct ownership by 33% to 40,000 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1785d
  SEC Form 4 filed by POWELL MICHAEL

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1785d
  SEC Form 4 filed by Cunningham Emmett

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1798d
  SEC Form 4 filed by Galera Therapeutics, Inc.

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1799d
  SEC Form 4: Alleva Lawrence M bought $34,741 worth of Common Stock (4,045 units at $8.59)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1800d
  SEC Form 4: West Linda bought $172,791 worth of Common Stock (20,000 units at $8.64)

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)
• 1903d
  SEC Form 4: A/S Holdings Novo sold $5,290,000 worth of COMMON STOCK (500,000 units at $10.58), decreasing ownership by 17% to 2,459,021 units

  4 - Galera Therapeutics, Inc. (0001563577) (Issuer)

Other GRTX categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends